Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
NCT05470205Phase 3Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Nov 2022
- Primary completion
- Feb 2028
- Modality
- Nanoparticles
- Countries
- 2
01
Overview
A Phase 3 trial of sonazoid, perflutren lipid microspheres in Portal Hypertension (PH), sponsored by Thomas Jefferson University. Started Nov 2022; status: recruiting.
02
Drugs
sonazoidperflutren lipid microspheres
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT05470205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05470205.